Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
Public ClinicalTrials.gov record NCT00442169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Placebo Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Lyophilized ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
Study identification
- NCT ID
- NCT00442169
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Enrollment
- 208 participants
Conditions and interventions
Conditions
Interventions
- ChimeriVax-WN02 Low Dose Biological
- ChimeriVax-WN02 Medium Dose Biological
- ChimeriVax-WN02 High Dose Biological
- 0.9% Saline solution Biological
- 0.9 % NaCl solution Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2005
- Primary completion
- May 31, 2008
- Completion
- Mar 31, 2009
- Last update posted
- Apr 13, 2016
2005 – 2009
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HOPE Research Institute | Phoenix | Arizona | 85050 | — |
| Idaho Infectious Diseases, PLLC | Idaho Falls | Idaho | 83404 | — |
| PRA International Clinical Pharmacology Center | Lenexa | Kansas | 66219 | — |
| Bio-Kinetic Clinical Applications, Inc. | Springfield | Missouri | 65802 | — |
| The Glennan Centre for Geriatrics and Gerontologyy, EVMS | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00442169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00442169 live on ClinicalTrials.gov.